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I. The molecular revolution
The advances in molecular biology confront mankind with a
fundamental transformation of our conception of nature, the depth of
which can only be compared with the birth of the modern natural
sciences in the seventeenth century and the revolutions in physics at
the beginning of the twentieth century. At the centre of the molecular
revolution is the recognition that all carbon-based life forms are based
on a self-reproducing sequence of data, whose ”programming
language” is based on the same ”letters” for all organisms. The
universality of the genetic code allows an abundance of
recombination possibilities for organic life. If ”this century was the
century of physics and chemistry”, as the American chemist and
Nobel Prize winner Robert Curl pronounced four years ago, then ”it’s
just as clear that the next century will be the century of biology”.
In the space of just a few decades scientists have discovered how to
decipher the code of life and make alterations feasible – through
genetic technology. Even allowing for due caution in terms of
estimates of the time frame for the thinkable and doable – consider the
extraordinary degree of speculation regarding human cloning – it’s
certain that the story of the molecular revolution will complete itself
in this new century. The nature of this technological quantum leap can
be reduced to four elements:
• The ability to intervene in the raw material of inheritance is the
heart of the molecular revolution. The applications of the future,
whether in human medicine, agriculture or environmental
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technology, will be based on the reprogramming of genetic
blueprints.
• Genetic resources will become the raw material and capital of a
new, globally active business area, whose diversification will be
based on the phalanx of computer technology and genetic
research, and which will nourish itself from the potential to
process, patent and possess DNA as a company-owned asset.
• Human beings will eventually become the object of their own
creative will through the retooling of the genetic material. The
natural history of humans will pass into a new age, where the
design of life is possible.
• The effects of this new ‘editability’ of humans will touch our
lives in quite immediate, practical and concrete ways. They will
force everybody to come to terms with this and arrive at their
own position one way or another.
It is not necessary to call on any creation myths to realise that modern
biotechnology touches on our own fundamental understanding of
what constitutes life, death and being human. This is exactly what is
new about this technology. On the other hand, what was true for
previous technological advances is also true for this one: the questions
and problems which are bound in with the new opportunities cannot
be simply reduced to either/or solutions, or indeed to the black and
white view of them in exaggerated emotional terms as blessing or
curse, opportunity or peril. The advantages of the potential
applications are great, just as their impact on society and individuals
will be enormous. Thus the scientific-technical revolution becomes an
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ethical, political, economic, social and psychological challenge,
which demands decisions: concerning values, goals and the way to get
there.
II. Life as information: the way we handle genetic data 
in the age of genetic analysis
In a few years, roughly about the time the human chromosome is
decoded, the means will be available to systematically investigate the
genetic strengths and weaknesses of broad swathes of mankind. This
knowledge of genetic dispositions demands an answer to the question
of who can access this genetic information, and under what
circumstances. The age of genetic analysis requires yet another
decision: societies will have to make up their minds about the extent
to which they want to make the new discoveries of genetics the basis
for a new standardisation of human life.
A legal framework for the use of genetic data
The ability to test people and find out if they are carriers of genes
which can predispose them towards numerous illnesses will belong to
the standard diagnostic repertoire within the next two decades. It will
be possible to carry out hundreds of genetic tests as routine and enable
doctors to assess the risk for diseases, physical limitations and
handicaps. In many cases this knowledge will be accompanied by new
diagnostic and therapeutic possibilities (e.g., tailored medicinal
treatments, gene therapies, recommendations for diets or lifestyle
adjustments), which can save lives or make them healthier and longer.
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Standards for the use
of genetic
information are
required
And yet, doctors will still frequently be faced with a predicted
condition where they are helpless, whenever diseases are detected
which are either untreatable or for which no treatment has yet been
found.
The characteristics of genetic analysis – comprehensive insight into
the genetic makeup, while holding no guarantee for therapy and cure
– have a great many legal consequences. In the future the right not to
know will become as important as the liability of those who offer
prognoses which turn out to be false. The right  will, however,
especially hinge on the extent to which third parties are informed, or
not, about the results of genetic diagnoses. This is particularly so in
relation to insurance, the job market and the penal system, where this
question will require precise rules within a clearly defined legal
framework:
• Thus private insurance policies (life insurance, unemployment
insurance, supplementary health care insurance, inter alia) will
increasingly argue that genetic information allows a more
precise assessment of the risks, and therefore a more equitable
calculation of the individual premiums. Particular diagnoses
may lead to people with certain genetic defects being classified
as being too high-risk and excluded from the protection provided
by insurance. In other cases they might perhaps be accepted, but
would have to pay significantly higher premiums. In such a
situation it would become a decision for society to make, as to
what extent (health) insurance systems, public as well as private,
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should provide a basic minimum system of benefits irrespective
of whatever genetic information that might be available.
• Information from genetic tests will also have an effect on the job
market. It will have to be resolved to what extent genetic
evidence can be consulted when judging potential employees or
those already working for a company.
• In the field of penal justice the genetic fingerprint will at some
point no longer merely be used to identify the perpetrators of
crime. Its potential lies far more in the area of general crime
prevention through databanks which store comprehensive
genetic profiles. Followed logically to its endpoint, this form of
prevention would lead to a databank which would store all
genetic profiles from birth. Such a national genetic register
would be, especially for a democracy, the inevitable and only
just solution, if one takes the view that particular subsets of the
population (ex-convicts, asylum-seekers, ethnic minorities)
should not be discriminated against in that one screens them
more intensively than the ”normal” population.
Genetics as the basis for a transformation of the norms 
of human society 
Legal regulations will in the future reflect how a society handles the
issue of genetic privacy and how it categorises forms of
discrimination based on the knowledge of genetic profiles. Beyond
this immediate consequence of the stockpiling of genetic information,
it will be increasingly difficult to duck the question, to what extent
predictions about the genetic makeup of citizens will create pressure
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towards a societal standardisation in the direction of a new definition
of the norms of human life.
This question can be most clearly isolated from the example of
prenatal diagnostics: prenatal diagnostics will be able within the next
decade to make an abundance of information about the still unborn
life available, which it will be possible to apply to a far greater degree
than has hitherto been possible. This will then make it possible, to a
certain extent, to select the types of children who should be delivered.
It’s already possible to diagnose over 800 inherited diseases such as
cystic fibrosis, Down’s syndrome and predisposition for various types
of cancer with the aid of genetic tests. At the moment, however, it is
still impossible to treat the causes of virtually all of these diseases,
with only a very few which can be treated up to now. It is, however,
to be expected  that many of these inherited conditions can be treated
at their source in the future.
Sexual selection of children in the womb is already a fact. In a country
like India, this leads to pregnant women mostly deciding to abort in
the case of the child being identified as female. What should make us
reflect on such future developments in the light of these decisions is
the fact that they are not taken in a social vacuum, but rather in the
context of social norms and attitudes.
In western societies the preference for male progeny may be unlikely.
However, a plausible scenario – especially under the paradigm of a
performance society – is the decision of parents to abort where the
genetic investigation of the foetus revealed the tendency towards a
later handicap, or perhaps merely because genes had been identified
which are suspected of being the cause of disadvantageous conditions
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such as obesity. Parents who, for whatever reason, despite such
diagnoses decide to bring children with ”defects” into the world,
would probably then be confronted with the attitude that ”that sort of
thing” doesn’t need to happen any more. Groups representing the
handicapped in the USA and Europe already argue that genetic tests
would influence the conception by society of what constitutes an
unacceptable handicap. Their concern is that the acceptance of the
handicapped will fall because of the distorting effect of genetic tests
on public opinion as to what normal and desirable attributes are, and
what not.
The conclusion of these reflections has to be that the greater the
knowledge of the human chromosome, the clearer the positions that
society must draw in terms of the degree to which it makes the genetic
knowledge the basis of value judgements and social norms. This is
also where the decision belongs, whether it is to be defined as
irresponsible to bring children into the world without having checked
their genetic data. Also the answer to the question as to how far
prenatal diagnostics and abortion may be committed to the goal of
bringing healthy progeny to the world and thereby reducing the social
costs of the care of the handicapped, is one that cannot be avoided.
It will also be a question of how to avoid genetics being used to lay
the basis for a slavish determinism, which, due to inadequate
knowledge of the scientific fundamentals, leads to an exaggeration of
the power of genes in many cases, whereas in others it underestimates
how much influence social conditioning and environmental factors
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can wield in the development of the individual.
The knowledge of the structure of the human chromosome
undoubtedly opens up a new dimension in the recognition and
successful treatment of genetically-linked diseases as well as the
ability at some point to select for certain genetic traits. Since Plato the
idea of producing a more perfect human being has been almost
continually addressed by philosophers. Apart from the fact that there
will probably never be agreement as to what physical and character
attributes such an ideal should possess, the philosophical discourse as
to what makes a good human being oscillates between the poles of
”good breeding” (determinism) and ”good upbringing” (humanism).
The perspectives of molecular biology have given a new facet to this
timeless debate. The idea of the genetically engineered  breeding of a
”Gutmensch”, with which the German philosopher Peter Sloterdijk
just recently unleashed an emotionally charged controversy in
Germany, overlooks the boundaries of genetic manipulation. Human
life is not the mechanical result of a predetermined genetic
configuration, but rather unfolds its specific form only as it interacts
with its physical and social environment. To this must be added the
complexity of genetic cause-and-effect relationships and structural
patterns. The predictability or the ability to steer genetic interventions
becomes less possible the greater the extent of the intended
transformation. Inherited behavioural patterns and cognitive traits
especially, e.g., high intelligence, are the result of the interaction of
many different genes. Whereas on the other hand most genes have not
one but rather several different functions. Sloterdijk’s allusion that
one could combat the socially decadent symptoms of today with a
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”genetic reform of the racial attributes” of human beings will
accordingly have to remain a philosophical parable. The nightmare
vision of the perfect ”generated” human obstructs the view of the real
societal questions which arise from the potential of gene technology.
Up to now the philosophical debate has too often taken place in an
ignorance of the realities of the genetic laboratories. Rational
discussions about the already existing applications of genetic
technology or those to be expected in the near future have remained
the exception. This creates the danger that the factual – e.g., the
increasing role of genetic engineering in agriculture, the conflicts
about the ownership of genetic resources or existing medical
applications – becomes a norm, without any significant debate in
society having taken place. On the way to finding societal norms in
our relationship with the new courses of action open to us, a continual,
interdisciplinary exchange among philosophy, sociology, the law and
science is an absolute prerequisite.
Modern societies will not be able to avoid accompanying the
molecular-medical advances with a comprehensive, wide-ranging and
thus costly awareness programme, which may resemble the
consciousness-raising of the AIDS campaigns, but which in terms of
expense will be significantly higher. This awareness campaign will
have to deal with sensitive issues such as genetic discrimination and
genetic determinism and make them into public educational themes
for all social classes. This effort to engender a rational acquaintance
with the issue will start with lessons in schools, ranging from there all
the way to a medical counselling system, which will put people in the
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position of being able to understand the genetic basis of the human
makeup and make responsible decisions for themselves and their
children.
III. Live longer, work longer: the influence of biomedicine
on the age structure and the social security systems 
of the industrialised societies
Advances in molecular biology will contribute substantially to a
further shift in the age pyramids in the prosperous industrial nations.
The numbers of the ”young elderly” will rise and people will be able
to work at a greater age than before. Reforms of the employment
market will therefore become unavoidable as the pressure to
modernise the system of retirement insurance grows. Whether or not
this also increases pressure to reform the health system depends on
how thoroughly biomedical advances are translated into affordable
treatments.
Consequences of the new age structures for labour market politics
The earth’s population is growing, migrating and getting older. Each
of these three aspects is of global importance, but population growth
is and will remain the largest problem for the earth’s development,
particularly for the less-developed countries.
The aging of humanity is, however, becoming an increasingly
important element of the demographic structural changes. There have
never been so many old people as today. The UN population report of
1998 predicted that the number of over-60s, currently c. 578 million,
12
The possibilities of
biotechnology will
accelerate the
demographic
transformation
Strengthening the
opportunities for
informed and
responsible decisions
will grow in the next 50 years to c. 1.5 billion. A fifth of the earth’s
population would then belong to this age group, which in China, for
example, is growing six times as fast as the total population.
The aging of society is particularly a feature of the industrialised
nations. The proportion of over-60s in those countries is already over
13.5% and is likely to reach the 33% mark by the middle of the
century. Germany, Japan, Italy and Sweden, for example, belong to
the group of most rapidly aging countries, where the proportion of
over-65s is already greater than 20% and will be around 40% in 50
years time.
Therefore, biomedicine will play a role as a factor which affects the
aging of society, especially in the industrialised countries with the
relatively highest prosperity levels. Biomedical progress, which is
taking place in these countries, will contribute to a further shift of the
age pyramid. The current state of research clearly indicates that future
generations will have the prospect of living longer, healthier lives.
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This also means that people will be able to work at an older age,
probably well into their seventh decade. The number of the ”young
elderly” will grow – a demographic change, which will have two
fundamental consequences:
The pressure for reform, which social security systems are faced with
anyway, will grow stronger. People will have to work longer to
maintain the financing of the pension system.
The shifts in the structure of the age pyramid have already for some
time knocked the relationship between those working and those
claiming pensions out of kilter. This applies especially to pay as you
go pension systems, which take money from the workers of today to
pay for the pensioners of today. According to the calculations of the
Worldwatch Institute, in industrialised economies an average of five
”workers” support one pensioner. By the year 2030 this relationship
will be 3:1; in Japan it will fall from the current 6:1 to 2:1. The
American example serves as a classic case to demonstrate the rise in
the costs of the pension system. When the retirement age of 65 was
introduced there, the standard life expectancy was 68. Today it is 76.
The list of possible strategies for reforming the old-age-insurance
systems is long; a series of measures (e.g., reduction of the amount
received as pension, partial or complete transition to (defined
contribution plans have already been undertaken, with varying
degrees of success. Despite detailed attempts to correct the existing
systems it is increasingly obvious that the deepest cut – raising the
retirement age – is inevitable. This will mean first of all that the
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adapt will increase
industrial nations will have to renounce all incentive programmes
which further early retirement. This may especially in Europe seem
unpopular, running as it does against current phenomena such as early
retirement programmes or reductions in the length of the working
week. In the medium term, however, such a step will be unavoidable
in a growing number of industrial nations, which find themselves with
ever more older people facing ever fewer younger. In principle this
situation could be addressed by permitting the immigration of
younger generations (in western Europe for example with increased
migration from the states adjoining the Mediterranean or central and
Eastern Europe). It is doubtful however if such a policy of
immigration would find acceptance in these societies, if only because
of emotionally-charged issues such as the integrity of the national
cultural heritage or the conservation of the national identity.
Many of the ” young elderly” will try to maintain their working
identities and work for longer, simply because they can work longer.
Modern societies will have to integrate working at previously
unaccustomed ages into their job market policies. It will partly be a
matter of strengthening the competence of these older workers
through further training and partly simply a matter of taking account
of and exploiting the knowledge and experience of these ”young
elderly” in the first place; in community projects, but indeed also in
the real employment world, especially in the realm of knowledge
transfer, and the training of the following generation.
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The  if-then relationship between medical progress and the costs of the
public health system
For the health system the effects of biomedical advances are not so
obvious as for the job market and the old-age-insurance systems. The
decisive question is clear: will it be possible to reduce spending on
health with the help of these advances in biomedical and gene
technology? The answer is, however, less clear. Whether a significant
reduction in costs is possible or not depends on two factors:
• It will be necessary to ensure that not only are more years added
to people’s lives, but also that the quality of life at an advanced
age is kept as high as possible. The goal is an older person who
remains self-sufficient for a long time and requires no intensive
care. Put in another way: the costs for health, care, medicine and
care of the elderly will only grow further if an increased life
expectancy mainly boosts the share of the population who will
have to battle with broken bones and the diseases of aging later
than before.
• Biomedical advances will also have to be converted into
affordable medicines and genetic treatments. Today, the answer
to this is far from clear:
It speaks against such a conversion that medical progress has up
to now always shown itself to be extremely cost-intensive. Most
of the currently applied uses of gene therapy for example (in
combination with drugs, counselling and other, supporting forms
of therapy) are strongly targeted, specially tailored to the
individual needs of the patients. To treat a large number of
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patients in this way would overwhelmed the basic coverage
systems of even the richest nations. The hi-tech rescue option
comprising gene therapy and corresponding medical support
would remain then as the privilege of those who can afford such
expensive treatment.
What does speak in favour of a translation of biomedical
progress into products which are reasonably priced, and
therefore effective on a broad scale, is a basic principle of free
market organisation, which also applies in the health market: the
larger the market, the greater the chance of the supply (in this
case drugs and therapies) satisfying the demand. The market of
the ”young elderly” represents a market with growth potential. A
redistribution of wealth on a large scale is occurring at the
moment in the wealthy industrialised nations. This is leading to
an unparalleled shift in purchasing power – from young to old.
Source: OECD Health Data 1999
Note: Total expenditures on health includes public and private spending. 
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Thus the share of the national income taken by the 18-35 year
olds halved between 1970 and 1995, while the share taken by
over-65s doubled. Whereas the average net income of a 70-year
old in 1970 was 40% below that of a 30year old, it is now 20%
higher.
A product trend is already clearly recognisable: the rapid increase in
the number of older people in the industrialised societies is leading
drug manufacturers to target their research efforts increasingly in the
direction of means of combating aging, which will keep older people
active longer and therefore significantly reduce the cost of their care.
The proximate goals in this respect will be the battle against age-
related conditions of the brain (Alzheimer’s, strokes, age-related
depression, inter alia), age-related cataracts, loss of hearing and
respiratory conditions.
IV. The economic exploitation of the gene: 
on the way to a new economic age
Genes are the stock market shares of biological progress. Market
forces have led to the patenting of genes or genetically engineered
tissues, organs and organisms, as well as the procedures which are
used in their transformation. The patenting of genetic resources
creates the framework for a new economic age, which will be
distinguished by the coexistence and cooperation of many small,
specialised start-up companies and large globally active
biotechnology corporations. The marketing of the gene will, in
particular, particularly drive three processes: it will make the right to
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the genetic raw material one of the most central political and
economic controversies of the new century. It will utterly transform
the nature of agriculture. And it will establish biotechnology as an
indispensable factor in a both productive and resource-efficient food
production.
Patenting of genetic resources
The earth’s gene pool will attain increasing commercial value in the
coming years. The more the global market uses technologies which
are based on genetics for the manufacturing of products and materials,
the more the value of genetically interesting plants, animals will rise.
Human populations will not escape this phenomena, as the decision of
the Icelandic parliament to sell the exclusive rights for research on the
population’s genetic code to a Swiss pharmaceutical concern for 200
million dollars in February 1999 shows.
The marketing of genetic resources will become a central political and
economic source of conflict principally because the great majority of
the desirable genes are to be found in the rich diversity of the tropical
regions, in Asia, Africa and Latin America. Plants from the rain
forests are especially interesting, because they may contain
compounds which can be exploited for new drugs.
The struggle for genetic resources has already begun and has occupied
international organisations like the UN’s FAO for more than 10 years.
This heralds a new north-south conflict for the next decade, which
will however be fought along old lines: the countries of the southern
hemisphere accuse multinational concerns of practising
bioimperialism and exploiting their national heritage – indigenous
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ressources as well as centuries-old orally transmitted knowledge of
the importance of this natural heritage – without appropriate
compensation. The pharmaceutical, chemical, agro-industrial or
biotechnology multinationals of the north maintain against this that
the market value will only be realised when they have processed,
modified and purified the genetic material. Patent protection is from
the point of view of the companies essential, if they are going to risk
devoting financial resources and years of research, in order to bring
new products to the market. A firm who does not patent, so goes the
justification, will lose out in competition with other firms.
The fact is that none of the international efforts to resolve this
situation – for example the Biodiversity Convention in 1992 and the
various follow-up conferences (most recently in Cartagena,
Colombia, in February 1999) –have been able to sort out any of the
disputes at issue. Apart from a series of issues, which are especially
concerned with the issue of biological security, open questions
include:
• to what extent the patenting of human cell lines leads to private
companies holding ownership rights on human life and what
consequences this may hold,
• what rules should govern the import and export of genetic
resources or genetically modified products (e.g., blood, cell lines
of microbes and plants, skeletal sections, fossil finds). Among
other issues, the relationship of the trade rules of the WTO to the
clauses of the Biodiversity Convention and other international
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environmental treaties remains unclear,
• whether guidelines for licensing contracts should be drawn up
which would offer financial compensation to the source regions
for the genetic resources and simultaneously provide protection
for affected species and ecological communities.
When genetic knowledge on a large scale arising from the decoding
of the human genome becomes available for patenting, we will see
conflicts developing which the public will take notice of, conflicts
which up to now have been almost entirely the province of lawyers
and lobbying groups. They will widen into a dispute fought at the
heart of society, where economic arguments, value-systems and
culturally influenced standards will clash with one another. This
conflict about the rights to genetic resources has the potential to
develop the same impact globally as the debate on human rights in the
second half of the last century.
Agriculture as hi-tech producer
Biotechnology will fundamentally alter the profile of agribusiness.
Soil, natural resources and labour as the characteristic limiting factors
of agriculture are rapidly losing importance. Agriculture is
increasingly becoming a hi-tech producer – capital intensive and
supported by laboratory research.
It is already true today that animal husbandry can not function without
this work in the laboratories. In-vitro fertilisation and embryo transfer
are ”state of the art” and have already cleared the way for the
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application of these technologies in the near future. The ability to
intervene precisely in chromosomes will probably be available for use
within the next ten years, enabling us to tailor the performance and
qualities of cattle and pigs. Animals with new functions will be
produced: sheep, goats, cattle, who produce the ingredients for
pharmaceuticals in their milk; or pigs which provide hearts, livers and
kidneys whose cells have been so altered that the human immune
system accepts them as being ”native”. Besides the economic and
medical benefits, however, care must be taken during the application
of gene technology to animal husbandry that the dignity of animal life
is also respected.
In crop husbandry the intervention of genetic engineering will achieve
the recombination of individual traits in order to strengthen the
resistance again viruses, pest insects, salt, frost and drought and to
guide the composition of nutrients. The use of genetic engineering
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Potential applications in
animal husbandry raise
ethical questions
Gene technology has
the potential to force
sustainable production
structures in agriculture
will not be confined to the altering of crop plants which will raise the
yield from the fields. There will also be more synthesised products,
which will be produced in labs and processed in factories, thereby
replacing the standard cultivation methods.
The agrarian structure of the future will be heavily influenced by
corporations which integrate the various different parts of the
production process, e.g., the development and production of fodder,
seeds, pesticides or fertilisers, into their product palette. The borders
between farmers, seed developers, fertiliser firms or food processing
factories will then begin to blur. In the age of globalisation life science
corporations, agro-concerns, food retailers and international trading
houses – just as in other areas (banking/insurance, telecommuni-
cations/media) – will begin to move towards forming joint ventures.
Alliances will crystallise, which will cover the whole spectrum from
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Acreage of Genetically Modified Plants by Country 
1996 1997 1998 Percentage
(Mio. ha) (Mio. ha) (Mio. ha) (1998, %)
USA 1,5 8,1 20,5 74
Argentina 0,1 1,4 4,3 15
Canada 0,1 1,3 2,8 10
Australia <0,1 0,1 0,1 1
Mexico <0,1 <0,1 0,1 1
Spain <0,1 <1
France <0,1 <1
South Africa <0,1 <1
Source: James Clive, Global Review of Commercialized Transgenic Crops,
1998 New York
Note: China is not considered in this graph, due to inexact data. Rough estimates
suggest that the crop area in China accounted for by genetically modified plants
in 1998 was c. 100,000 ha.
Increasing integration
of corporate structures
in the food and
agricultural industry
research cooperation for the decoding and patenting of plant and
animal genomes to seed and harvest as far as production and sales of
foodstuffs.
The hi-tech transformation of agriculture will come to pass as a
globally applicable pattern in every modern industrialised society in
this new century, even if there are significant differences between
current developments in Europe and North America. For example, in
the 1999 in the USA more than half of the soya and more than a third
of the maize harvest was accounted for by genetically engineered
seed. In Canada and Argentina one can also speak of an alliance
between the large-scale agro-enterprises and the biotechnology
industry. In the face of this the European governments, agricultural
organisations, retail chains and consumers are at the moment reacting
overwhelmingly to reject the application of gene technology in
agriculture. A similar picture is to be seen in some Asian countries,
e.g., Japan. Indeed American consumers are beginning to regard
genetically manipulated foodstuffs with suspicion. The current
mixture of unqualified support, reservations, distrust and sitting on
the fence is however merely a temporary phenomenon. Narrow
international economic inter-dependence will result in the various
market structures and levels of regulation converging. Improved
knowledge and awareness of the opportunities and avoidance of
environmental and health risks will lead in the medium term to a
sinking of the range of prejudices – especially the emotional ones –
which green genetic technology is faced with at the moment, or at
least to a more rational and differentiating point of view which will
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Large differences in the
extent and regulation of
biotechnical applications
in agriculture
International
competition will lead
to a harmonisation of
market structures and
regulatory regimes
cause legal obstacles eventually to fall.
Although often brandished by the critics of biotechnology, the
question as to what extent the dominance of biotechnological
agribusiness uproots farmers from their land, is of minor importance
in the European industrial nations. Smaller units play an ever smaller
role, although they will survive in a niche function due to their
importance for the countryside. Asia presents a different picture. In
some countries of this region, its quite conceivable that biotechnology
will interfere with traditional cultural and social structures; namely
where corporations succeed more and more in producing things which
belong to the traditional range of cash crops, and therefore to the local
economic basis, or perhaps when it proves possible to make substitute
cheaper laboratory-produced substances. Thus, in contrast to North
America and Europe, the loss of agricultural jobs must be calculated
as a factor for social unrest. The rural family and the village may be
of declining importance in the West, but in many parts of Asia they
still stand for an important degree of social stability and continuity.
Indispensable, but inadequate: biotechnology and genetics as an
element in the war against world hunger
The cultivable areas available worldwide can hardly be extended any
more. Especially for this reason biotechnology will develop to an
indispensable element in the food production process. Fundamental
problems of global nutrition will not however be solved by
biotechnology alone. In the future the main challenges to securing
adequate nutrition will still be linked to social and structural policies.
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Biotechnology will
alter the social and
economic structures
of rural areas
Only by combining gene
technology and
politically-guided
distributive measures will
it be possible to attack
the global nutrition
problem effectively
Among other factors, it is a matter of facilitating the access to food in
the poorest regions, while at the same time improving the health
services and strengthening the role of women in terms of care for
mothers and children, as the World Nutrition Summit in Rome in 1996
correctly emphasised.
In the last ten years c. 240 billion tonnes of soil (which is equivalent
to more than half of the total tillage area of the USA) has been lost
through overfertilisation, deforestation, erosion, inappropriate
irrigation methods and extravagant application of herbicides.
Industrialisation and the growth of urban areas also contribute to the
destruction of arable areas. The extension of agricultural areas is only
a temporary solution. Sooner or later, there will not be any more land
that is suitable for cultivation. In a global context at best parts of
Brazil, Colombia, Venezuela and African states south of the Sahara
still have potential to be converted to additional arable land. This
would, however, have a disproportionate and destructive impact on
the biological diversity of these regions.
Therefore the necessary growth in production will have to be
achieved through more intensive exploitation of existing cultivated
areas. Modern biotechnology offer the potential for this
intensification. Advances in the genetic manipulation of crops like
maize, rice and wheat will make it possible to increase the yields from
the existing fields and in a more environmentally friendly way than
hitherto possible. An adequate level of production can be guaranteed
in this way. The difficulties named above, distribution above all, will
however remain.
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The growing world
population demands
increased agricultural
productivity 
Apart from some cooperative projects in the development aid and
scientific research domains, there still remains no convincing strategy
as to how biotechnology can be put to work for the countries which
suffer most from hunger and malnutrition, particularly the countries
of Southeast Asia and Sub-Saharan Africa. Most of the crops which
have been genetically manipulated up to now have been intended for
the agricultural systems of the capital-rich, industrialised states. This
is where the markets are for a biotech-supported agriculture. In only a
few cases are the life science corporations examining the classical
staple crops of developing countries such as sweet potato or cassava
(manioc), the basic source of nourishment for 500 million people in
Africa, South America and southern India. If biotechnology are
ultimately also recruited in the fight against world hunger, its
advantages must also be directed to the countries who cannot afford
either these technologies or their own research efforts. 
V. Reprogramming the human animal: 
how the changeability of humanity 
forces value-based decisions
Genetic technology facilitates changes to human nature in areas
which up to now were considered to be impossible to manipulate.
Humanity will be confronted with a decision which, for Edward O.
Wilson, the founder of sociobiology, constitutes the ”most sensitive”
question, before which it has ever stood: To what extent will existing
generations alter the gene pool of coming generations and thereby
themselves determine the development of human evolution? This
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application of modern
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Green biotechnology
must also adapt to the
needs of those in the
areas most threatened
by hunger
question could divide broad sections of the human race into two
camps of conflicting convictions: the people who support rebuilding
the human constitution would be opposed by all those who would
reject this step. The moral underpinning of the technically doable and
the striving for the fulfilment of personal wishes are the driving forces
on the way there.
The modern industrialised societies will, at different rates and with
different nuances, adapt themselves to the technical-medical
changeability of humans. There will also be a small number of
countries, who with regard to particular issues – Germany, for
example, in the field of embryonic research – will proceed in a more
restrictive manner than others and decide to follow a separate path.
The existing differences become clear when one looks at the debate
provoked by the American philosopher Francis Fukuyama and the
controversy sparked off by Peter Sloterdijk in Germany concerning
changing the basic genetic material. Whereas the discourse in the
USA about the patterns of motivation and social impact of genetic
technology has been conducted so far in a tone of rationality and
taboo-free space, the philosophical schools of thought in Europe have
thrown themselves into a bitter ”Kulturkampf” about the ethics of
genetic engineering.
However, international bans or wide-ranging moratoria on issues such
as cloning and germ line therapy will never come to pass. There are
two decisive reasons for this, which become apparent when one looks
at the political-ethical debate in the USA – the country which meets
the redesign of humans with a great degree of openness and whose
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attitude to biotechnology will have a substantial influence on the way
chosen into the future.
• The faster knowledge strides ahead and the more sophisticated
technologies become, the more difficult it will be to set
boundaries on what the biological sciences are capable of doing,
but should not do. That is the core of the argument which has
dominated the debate in the USA for some time and has led to
the situation at the current state of the technology, where
American molecular geneticists have refused to restrict their
research efforts, especially in the area of germ line therapy. They
argue from the basis of the enormous medical potential of this
therapy, whereby genetic intervention normally does not just
affect the treated individual, but will also be inherited by their
descendants. Its therapeutic potential would consist of the ability
to deliberately manipulate the sexual germ cells, in order for
example to eliminate family-inherited diseases or to achieve a
natural immunity against infectious diseases like malaria or
tuberculosis. When one day the risks and side effects of this
therapy have been researched through painstaking preliminary
research and can be avoided, then this would provide a moral
backing for the technically doable. Arthur Caplan, founding
president of the American Association of Bioethics, therefore
calls the possibility of once and for all correcting at the source
inherited conditions like spina bifida, anencephaly, haemophilia,
muscular dystrophy or Huntingdon’s chorea a blessing, ” which
makes this germ line therapy a moral obligation”. The message
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The speed of progress
handicaps political
regulation efforts
which this statement is based on marks the only probable
concrete and practical aid to decision-making, with which
bioethical discussion can support societal decision-making in the
future: a farewell to taboos, focusing instead on the concrete,
i.e., the examination of each case on its merits based on precisely
defined premises and indications.
• The advances to date in the fields combining reproductive
medicine and intervention in the genome backed up by the
evident continual rate of progress will lead to a variety of
methods of creating progeny in different ways. Parents and
individuals will deploy their financial means to ensure that their
children have the best chances for a healthy and successful life.
The claim to the right to individual happiness, as is especially
evident in the western industrial states, will be large enough to
allow a market for genetic improvement to develop, which will
help itself to the appropriate advances in science.
For the USA the molecular geneticist Lee Silver estimates that already
by 2005 half a million babies will be brought into the world through
various genetically supported procedures of in-vitro fertilisation
(IVF). The insistence on an ethical argument, namely that of the
inalienable right of the individual to make autonomous decisions over
his own body and that of his descendants, without interference from
state, church or society, plays the principal role here. Provided that the
path to genetically corrected humans can be medically and technically
justified and supported – against what law would parents offend, if
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and personal freedom
they contrived to give their progeny every available advantage, by
providing him with the genes in the cradle which would prevent the
occurrence of asthma or obesity, or the tendency towards heart
aliments or diabetes?
The wish to give one’s own next generation the best possible of what
is available is morally impossible to condemn as a single case.
Modern societies will therefore have great difficulty in denying the
procreators an equal say about the genetic equipping of their children.
On a wider scale however, the individual claim to happiness conceals
a certain element of social dynamite. The intervention in the genome
may lead to a social polarisation for coming generations: a gulf
between those who can afford to provide their children with
advantages in life through genetic manipulation and those who will
remain excluded from these possibilities. The substance of these
scenarios of genetically privileged and genetic have-nots will only
apply – at least as far as the prosperous industrial societies are
concerned – for an interim period. It will be weakened as soon as
genome manipulation becomes financially accessible for broad
swathes of the population. The real, the more deep-lying antagonism,
which might lead to a fundamental drifting apart of different camps of
humanity, would be that between those who applaud the redesign of
human beings and those who do not want what is possible – whether
it’s from religious motives, cultural conventions or in a romanticised
wallowing in the laws of nature.
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Further literature, documents and Internet links on the subject of
genetic and biotechnology:
The portal ”Biotechnology” maintained by the research group Global
Future (www.aventis-forum.uni-muenchen.de) offers a selection of
important documents and internet links on the issues dealt with here
as well as additional literature recommendations in English and
German.
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